The recent emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the underlying cause of Coronavirus Disease 2019 (COVID-19), has led to a worldwide pandemic causing substantial morbidity, mortality, and economic devastation. In response, many laboratories have redirected attention to SARS-CoV-2, meaning there is an urgent need for tools that can be used in laboratories unaccustomed to working with coronaviruses. Here we report a range of tools for SARS-CoV-2 research. First, we describe a facile single plasmid SARS-CoV-2 reverse genetics system that is simple to genetically manipulate and can be used to rescue infectious virus through transient transfection (without in vitro transcription or additional expression plasmids). The rescue system is accompanied by our panel of SARS-CoV-2 antibodies (against nearly every viral protein), SARS-CoV-2 clinical isolates, and SARS-CoV-2 permissive cell lines, which are all openly available to the scientific community. Using these tools, we demonstrate here that the controversial ORF10 protein is expressed in infected cells. Furthermore, we show that the promising repurposed antiviral activity of apilimod is dependent on TMPRSS2 expression. Altogether, our SARS-CoV-2 toolkit, which can be directly accessed via our website at https://mrcppu-covid.bio/ , constitutes a resource with considerable potential to advance COVID-19 vaccine design, drug testing, and discovery science. To help meet the ensuing demand for COVID-19 reagents, this article presents an openly available ‘coronavirus toolkit’ ( https://mrcppu-covid.bio ) and describes the generation and validation of these tools, including a simple SARS-CoV-2 reverse genetics system and a near-comprehensive panel of SARS-CoV-2 antibodies.
【저자키워드】 TMPRSS2, 【초록키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, Coronavirus disease 2019, Coronaviruses, coronavirus, COVID-19 vaccine, Mortality, Vaccine design, antiviral activity, severe acute respiratory syndrome Coronavirus, coronavirus 2, genetics, Laboratory, SARS-CoV-2 antibodies, Viral, SARS-CoV-2 antibody, morbidity, Scientific community, Drug testing, clinical isolates, respiratory, resource, apilimod, Infectious virus, cell lines, Plasmid, Viral protein, acute respiratory syndrome coronavirus, website, infected cells, reagents, worldwide pandemic, help, additional expression plasmids, discovery science, economic devastation, expression plasmids, facile single plasmid SARS-CoV-2 reverse genetics system, near-comprehensive panel, ORF10 protein, promising repurposed antiviral activity, SARS-CoV-2 clinical isolates, SARS-CoV-2 permissive cell lines, SARS-CoV-2 research, TMPRSS2 expression, transient transfection, COVID-19 vaccine design, SARS-CoV-2 toolkit, can be used, expressed, dependent on, in vitro transcription, accompanied, 【제목키워드】 SARS-CoV-2, genetics, Plasmid, COVID-19 research, coronavirus toolkit,